The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage

Abstract Background Cardiac involvement in Fabry Disease (FD) occurs prior to left ventricular hypertrophy (LVH) and is characterized by low myocardial native T1 with storage reflected by cardiovascular magnetic resonance (CMR) and ECG changes. Objectives We hypothesize that a pre-storage myocardial...

Full description

Saved in:
Bibliographic Details
Published inEuropean heart journal Vol. 41; no. Supplement_2
Main Authors Bicho Augusto, J.A, Johner, N, Shah, D, Nordin, S, Knott, K, Lau, C, Alfarih, M, Seraphim, A, Vijapurapu, R, Ramaswami, U, Steeds, R, Kozor, R, Hughes, D, Moon, J, Namdar, M
Format Journal Article
LanguageEnglish
Published 01.11.2020
Online AccessGet full text

Cover

Loading…
Abstract Abstract Background Cardiac involvement in Fabry Disease (FD) occurs prior to left ventricular hypertrophy (LVH) and is characterized by low myocardial native T1 with storage reflected by cardiovascular magnetic resonance (CMR) and ECG changes. Objectives We hypothesize that a pre-storage myocardial phenotype might occur even earlier, prior to T1 lowering. Methods FD patients and age, sex and heart rate matched healthy controls underwent same-day ECG with advanced analysis and multiparametric CMR (cines, global longitudinal strain [GLS], T1 and T2 mapping, stress perfusion [myocardial blood flow, MBF] and late gadolinium enhancement [LGE]). Results 114 Fabry patients (46±13 years, 61% female) and 76 controls (49±15 years, 50% female) were included. In pre-LVH FD (n=72, 63%), a low T1 (n=32/72, 44%) was associated with a constellation of ECG and functional abnormalities compared to normal T1 FD patients and controls. However, pre-LVH FD with normal T1 (n=40/72, 56%) also had abnormalities compared to controls: reduced GLS (−18±2 vs −20±2%, P<0.001), microvascular changes (lower MBF 2.5±0.7 vs 3.0±0.8mL/g/min, P=0.028), subtle T2 elevation (50±4 vs 48±2ms, p=0.027) and limited LGE (%LGE 0.3±1.1 vs 0%, P=0.004). ECG abnormalities included shorter P wave duration (88±12 vs 94±15ms, P=0.010) and T wave peak time (Tonset–Tpeak; 104±28 vs 115±20ms, P=0.015), resulting in a more symmetric T wave with lower T wave time ratio (Tonset–Tpeak)/(Tpeak–Tend) (1.5±0.4 vs 1.8±0.4, P<0.001) compared to controls. Conclusions FD has a measurable myocardial phenotype pre-LVH and pre-detectable myocyte storage with microvascular dysfunction, subtly impaired GLS and altered atrial depolarization and ventricular repolarization intervals. Proposed stages of cardiac involvement Funding Acknowledgement Type of funding source: None
AbstractList Abstract Background Cardiac involvement in Fabry Disease (FD) occurs prior to left ventricular hypertrophy (LVH) and is characterized by low myocardial native T1 with storage reflected by cardiovascular magnetic resonance (CMR) and ECG changes. Objectives We hypothesize that a pre-storage myocardial phenotype might occur even earlier, prior to T1 lowering. Methods FD patients and age, sex and heart rate matched healthy controls underwent same-day ECG with advanced analysis and multiparametric CMR (cines, global longitudinal strain [GLS], T1 and T2 mapping, stress perfusion [myocardial blood flow, MBF] and late gadolinium enhancement [LGE]). Results 114 Fabry patients (46±13 years, 61% female) and 76 controls (49±15 years, 50% female) were included. In pre-LVH FD (n=72, 63%), a low T1 (n=32/72, 44%) was associated with a constellation of ECG and functional abnormalities compared to normal T1 FD patients and controls. However, pre-LVH FD with normal T1 (n=40/72, 56%) also had abnormalities compared to controls: reduced GLS (−18±2 vs −20±2%, P<0.001), microvascular changes (lower MBF 2.5±0.7 vs 3.0±0.8mL/g/min, P=0.028), subtle T2 elevation (50±4 vs 48±2ms, p=0.027) and limited LGE (%LGE 0.3±1.1 vs 0%, P=0.004). ECG abnormalities included shorter P wave duration (88±12 vs 94±15ms, P=0.010) and T wave peak time (Tonset–Tpeak; 104±28 vs 115±20ms, P=0.015), resulting in a more symmetric T wave with lower T wave time ratio (Tonset–Tpeak)/(Tpeak–Tend) (1.5±0.4 vs 1.8±0.4, P<0.001) compared to controls. Conclusions FD has a measurable myocardial phenotype pre-LVH and pre-detectable myocyte storage with microvascular dysfunction, subtly impaired GLS and altered atrial depolarization and ventricular repolarization intervals. Proposed stages of cardiac involvement Funding Acknowledgement Type of funding source: None
Author Nordin, S
Seraphim, A
Bicho Augusto, J.A
Johner, N
Knott, K
Moon, J
Ramaswami, U
Kozor, R
Shah, D
Lau, C
Hughes, D
Steeds, R
Alfarih, M
Vijapurapu, R
Namdar, M
Author_xml – sequence: 1
  givenname: J.A
  surname: Bicho Augusto
  fullname: Bicho Augusto, J.A
  organization: University College London, London, United Kingdom
– sequence: 2
  givenname: N
  surname: Johner
  fullname: Johner, N
  organization: Geneva University Hospitals, Cardiology Division, Geneva, Switzerland
– sequence: 3
  givenname: D
  surname: Shah
  fullname: Shah, D
  organization: Geneva University Hospitals, Cardiology Division, Geneva, Switzerland
– sequence: 4
  givenname: S
  surname: Nordin
  fullname: Nordin, S
  organization: Barts Health NHS Trust, London, United Kingdom
– sequence: 5
  givenname: K
  surname: Knott
  fullname: Knott, K
  organization: University College London, London, United Kingdom
– sequence: 6
  givenname: C
  surname: Lau
  fullname: Lau, C
  organization: Barts Health NHS Trust, London, United Kingdom
– sequence: 7
  givenname: M
  surname: Alfarih
  fullname: Alfarih, M
  organization: University College London, London, United Kingdom
– sequence: 8
  givenname: A
  surname: Seraphim
  fullname: Seraphim, A
  organization: University College London, London, United Kingdom
– sequence: 9
  givenname: R
  surname: Vijapurapu
  fullname: Vijapurapu, R
  organization: Queen Elizabeth Hospital Birmingham, Department of Cardiology, Birmingham, United Kingdom
– sequence: 10
  givenname: U
  surname: Ramaswami
  fullname: Ramaswami, U
  organization: Royal Free Hospital, lysosomal storage disorders unit, London, United Kingdom
– sequence: 11
  givenname: R
  surname: Steeds
  fullname: Steeds, R
  organization: Queen Elizabeth Hospital Birmingham, Department of Cardiology, Birmingham, United Kingdom
– sequence: 12
  givenname: R
  surname: Kozor
  fullname: Kozor, R
  organization: University of Sydney, Sydney Medical School, Sydney, Australia
– sequence: 13
  givenname: D
  surname: Hughes
  fullname: Hughes, D
  organization: Royal Free Hospital, lysosomal storage disorders unit, London, United Kingdom
– sequence: 14
  givenname: J
  surname: Moon
  fullname: Moon, J
  organization: Barts Health NHS Trust, London, United Kingdom
– sequence: 15
  givenname: M
  surname: Namdar
  fullname: Namdar, M
  organization: Geneva University Hospitals, Cardiology Division, Geneva, Switzerland
BookMark eNot0E1qwzAQBWBRUmiS9gJd6QJO9WPJ1rKEpi0EunGhOzOSRrVDYhnJG9--SZrNPJgHb_GtyGKIAxLyzNmGMyNfsDu4_nwBTKk3gktxR5ZcCVEYXaoFWTJuVKF1_fNAVjkfGGO15npJmqZDepqjg-R7ONKxwyFO84g0BroDm2bq-4yQkY4Ji-7cpCnFsZspDP768zihm8AekeYpJvjFR3If4Jjx6ZZr8r17a7Yfxf7r_XP7ui8cF0oUEHxgFat4FayxSgCXUtQsWCsRUXlfS12VYBxwXmJpHBOVL6W2lRbMaiXXRPzvuhRzThjaMfUnSHPLWXtxaa8u7c2lvbjIPxm7W8o
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1093/ehjci/ehaa946.2132
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-9645
ExternalDocumentID 10_1093_ehjci_ehaa946_2132
GroupedDBID ---
-E4
.2P
.I3
.XZ
.ZR
08P
0R~
18M
1TH
29G
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAJKP
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
AAYXX
ABEUO
ABIXL
ABKDP
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQNK
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCGUY
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CITATION
CS3
CZ4
DAKXR
DIK
DILTD
D~K
E3Z
EBS
EE~
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IOX
J21
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M41
M49
MHKGH
ML0
N9A
NGC
NOMLY
NOYVH
NU-
O9-
OAUYM
OAWHX
OB3
OCZFY
ODMLO
OGROG
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
ROZ
RUSNO
RW1
RXO
SEL
TCURE
TEORI
TJX
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
ID FETCH-LOGICAL-c1252-afdf070717fb9b52a133280fbb3eee5dd83674a9ca114e49c027d436b7620b653
ISSN 0195-668X
IngestDate Thu Sep 12 18:58:02 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Supplement_2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1252-afdf070717fb9b52a133280fbb3eee5dd83674a9ca114e49c027d436b7620b653
OpenAccessLink https://archive-ouverte.unige.ch/unige:148838/ATTACHMENT01
ParticipantIDs crossref_primary_10_1093_ehjci_ehaa946_2132
PublicationCentury 2000
PublicationDate 2020-11-01
PublicationDateYYYYMMDD 2020-11-01
PublicationDate_xml – month: 11
  year: 2020
  text: 2020-11-01
  day: 01
PublicationDecade 2020
PublicationTitle European heart journal
PublicationYear 2020
SSID ssj0008616
Score 2.3914447
Snippet Abstract Background Cardiac involvement in Fabry Disease (FD) occurs prior to left ventricular hypertrophy (LVH) and is characterized by low myocardial native...
SourceID crossref
SourceType Aggregation Database
Title The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage
Volume 41
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS8MwFA86QbyIn_hNDt5GtzZN0vYoogxhO22wW0na1Cq4Se0O-tf7kmZtJxOcl1K68Wj7fk3e-70vhG496VKaeKEjM5eCg5LCGUsz-OIjxoSbUao03zEc8cGEPk3ZtIngm-qSUvaSr7V1Jf_RKlwDveoq2Q00WwuFC3AO-oUjaBiOf9bx2yfsRoUp_9DpWnPDqYIF-Chk8bmMv-hWAE4OvxRlMYcXu2wP4KRKBxFM-ZROkxSrmUE1Va_HXpfd9j0ZXh2Wzu7d4nnxUVbxm14Nh6e6kqYJ9eQiX0kxHoHf-9KiXy33AI6mV3MPlo6MmMO5GQ4Mu4ldQsG9jXjVJHK5xlKvhSUzr9SQnzFZu4pXHa5U_poYveZCRJT3iGeZ0JWm2T82szrFsAqu-7GRElsZsZaxjXZIAEjUleHTJh8o5GZObv1ItsIKZPSNjH77PlpWTMscGR-gfetH4LsKFIdoS82O0O7QZkocozFgAzfYwDU28DzDBhvYYgP_wAYGbOBVbGCLjRM0eXwY3w8cO0HDScBwJY7I0kz3c_KCTEaSEeH5PgndTEpfKcXSNPR5QEWUCHCLFY0SlwQp9bmELdKVnPmnqDObz9QZwmnAqOS-IAl8wKFHJXEFpwIM2JCzSIpz1F2-kfi9apQS_66Di43-fYn2GvRdoU5ZLNQ12IKlvDE6_AbiSWIh
link.rule.ids 315,786,790,27955,27956
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+myocardial+phenotype+of+Fabry+disease+pre-hypertrophy+and+pre-detectable+storage&rft.jtitle=European+heart+journal&rft.au=Bicho+Augusto%2C+J.A&rft.au=Johner%2C+N&rft.au=Shah%2C+D&rft.au=Nordin%2C+S&rft.date=2020-11-01&rft.issn=0195-668X&rft.eissn=1522-9645&rft.volume=41&rft.issue=Supplement_2&rft_id=info:doi/10.1093%2Fehjci%2Fehaa946.2132&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_ehjci_ehaa946_2132
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon